PARX HEAL Stock

PRLX

US69916A1051

Delayed OTC Markets			5-day change	1st Jan Change
- ^USD	-.--%		-.--%	-

22-03-28	Parallax Health Sciences Inc. Announces Executive Changes	CI
22-03-28	Parallax Health Sciences Inc. Terminates Sonia Choi as Interim CEO	CI

Parallax Health Sciences, Inc. focuses on personalized patient care through the use of the Company's Compound Pharmacy (Roxsan, Inc.) and eventually through the diagnostic testing platform capable of diagnosing and monitoring various health issues. The Company's segments include Retail Pharmacy Services (RPS) and Corporate. The RPS segment provides a range of pharmacy services, including retail, compounding and fertility medications. The Corporate segment provides management and administrative services to support the Company. The RPS segment dispenses prescription drugs, both through local channels by direct delivery, as well as mail order. The RPS segment also sells an assortment of general merchandise, including over-the-counter drugs, beauty products and cosmetics, seasonal merchandise and convenience foods, through the Company's pharmacy. It holds interests in Quality of Life Peace of Mind (QOLPOM). The QOLPOM Hub is a personal medication dispensing and remote monitoring solution.

Employees

Sector

More about the company

Market Cap	2.51M 2.16M 2.03M 1.86M 3.47M 237M 3.48M 24.02M 9.32M 122M 9.43M 9.22M 392M	P/E 2018	1.35x	P/E 2019	-0.94x
Enterprise Value	6.03M 5.19M 4.88M 4.46M 8.35M 570M 8.37M 57.71M 22.4M 292M 22.65M 22.16M 941M	EV / Sales 2018	1,568,116,279x	EV / Sales 2019	136,778,344x
Free-Float	-	Yield 2018 *	-	Yield 2019	-

22-03-28	Parallax Health Sciences Inc. Announces Executive Changes	CI
22-03-28	Parallax Health Sciences Inc. Terminates Sonia Choi as Interim CEO	CI
21-09-29	Parallax Health Sciences, Inc. Appoints Sonia Choi as Interim Chief Executive Officer	CI
21-08-23	Parallax Health Sciences, Inc. Announces Executive Changes	CI
21-07-13	Parallax Health Sciences Inc. Announces Resignation of Paul R. Arena as Chief Executive Officer	CI
21-07-13	Parallax Health Sciences Inc. Announces Management Changes	CI
21-04-08	Parallax Health Sciences, Inc. Announces Resignation of Capt. E. William Withrow Jr. from its Board and Chair of the Compensation Committee, Deputy Chair of the Audit Committee and Co-Chair of the Governance Committee	CI
20-05-18	Parallax Health Sciences Inc. Reports Earnings Results for the Full Year Ended December 31, 2019	CI
20-05-17	Parallax Health Sciences, Inc. Auditor Raises 'Going Concern' Doubt	CI
20-04-09	Parallax Health Sciences, Inc. Announces Executive Changes	CI
20-03-25	Parallax Health Sciences, Inc. Launches Secure Good Health Outcomes Telehealth Application for Immediate Free Download	CI
20-03-24	Parallax Health Sciences, Inc. Updates Progress on Proprietary COVID-19 Rapid Test	CI
20-03-16	Parallax Health Sciences, Inc. Receives Approval on its Registration Into U.S. Government's System for Award Management,	CI

22-05-12	PARALLAX HEALTH SCIENCES, INC. : Entry into a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Financial Statements and Exhibits (form 8-K)	AQ
22-03-28	PARALLAX HEALTH SCIENCES, INC. : Change in Directors or Principal Officers (form 8-K)	AQ
21-09-29	PARX HEAL : EXECUTIVE AGREEMENT (Form 8-K)	PU
21-09-29	PARALLAX HEALTH SCIENCES, INC. : Entry into a Material Definitive Agreement, Change in Directors or Principal Officers, Financial Statements and Exhibits (form 8-K)	AQ
21-08-31	PARALLAX HEALTH SCIENCES, INC. : Entry into a Material Definitive Agreement, Other Events (form 8-K)	AQ

Date	Insider	Type	Main position	Quantity	% Market Cap.
1/14/22	Edward Withrow	Others	Director	20,541,826	7.5878%
12/31/21	Edward Withrow	Others	Director	18,921,420	6.9892%
12/31/21	Edward Withrow	Others	Director	1,228,749	-

	2018	2019
Net sales	0.01 0.01 0.01 0.01 0.02 1.11 0.02 0.11 0.04 0.57 0.04 0.04 1.83	0.13 0.11 0.1 0.1 0.18 12.14 0.18 1.23 0.48 6.23 0.48 0.47 20.07
Net income	16.29M 14.02M 13.19M 12.05M 22.54M 1.54B 22.6M 156M 60.47M 789M 61.17M 59.83M 2.54B	-12.87M -11.07M -10.42M -9.52M -17.8M -1.21B -17.85M -123M -47.76M -623M -48.31M -47.26M -2.01B
Net Debt	2.95M 2.53M 2.38M 2.18M 4.08M 278M 4.09M 28.18M 10.94M 143M 11.06M 10.82M 460M	3.52M 3.03M 2.85M 2.61M 4.87M 333M 4.89M 33.7M 13.08M 171M 13.23M 12.94M 550M

PARX HEAL Stock

Stocks

PRLX

US69916A1051

Valuation : PARX HEAL

Latest news : PARX HEAL

Press Releases : PARX HEAL

Latest insider transactions

Financials

Company Profile